TRIB News and Press, Trinity Biotech plc From 04/11/22

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the “Company”), today announced a $45 million strategic investment and partnership with MiCo Ltd (“MiCo”...

Trinity Biotech (NASDAQ:TRIB) announced on Monday that the World Health Organisation (WHO) approved its new HIV screening product, TrinScreen HIV. In Africa, Trinity Biotech (TRIB) has led the market for HIV confirmatory tests for many years, and the company has designed TrinScreen HIV, speci...

DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (WHO). TrinScreen™ HIV Trinity Biotech’s Uni-Gold™ HIV...

DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced that it has closed its recently announced refinancing. Refinancin...

DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Extraordinary General Meeting (EGM). EGM Result...

Trinity Biotech (NASDAQ:TRIB): Q3 Non-GAAP EPADS of $0.09 in-line; GAAP EPADS of $0.06 misses by $0.03. Revenue of $22M (-31.3% Y/Y) misses by $4M. Press Release The Group’s cash balance at the end of Q3, 2021 was $27.5M compared to $28.6M at the end of Q2, 2021. For further details ...

DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2021, th...

Presentation Times and Weblinks Released for Over 130 Presenting Companies Wednesday and Thursday, September 22 - 23, 2021 NEW YORK, NY / ACCESSWIRE / September 21, 2021 / Sidoti & Company, LLC proudly releases the presentation schedule, with weblink click-throughs, for its Si...

Trinity Biotech plc (TRIB) Q2 2021 Earnings Conference Call September 9, 2021 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Ronan O’Caoimh - Chairman and Chief Executive Officer John Gillard - Chief Financial Officer and Director Conference Call Participants Jim Sidoti - ...

Gainers: ProQR Therapeutics (NASDAQ:PRQR) +22%, Centessa Pharmaceuticals CNTA +22%, Kiromic BioPharma (NASDAQ:KRBP) +19%, Trinity Biotech TRIB +16%, Enveric Biosciences (NASDAQ:ENVB) +14%. Losers: Humanigen HGEN -54%, Invacare IVC -34%,&#...